An End to Baldness?

The fascinating cure-finding just never ends. It seems that one day, even baldness may be something that no one has to live with unless they just want to be smoothy and shiny up-top.

A study published in the Journal of Cosmetic Dermatology (official journal of the European Society for Cosmetic and Aesthetic Dermatology) used identical twins with male pattern hair loss (known technically as androgenetic alopecia) to explore the efficacy of dutasteride, a particular enzyme inhibitor, as a means of reducing hair loss and encouraging new growth.

Because of their identical genetics, twins make great scientific study subjects. In this research, for example, one twin took the medication while the other took a placebo. Hair loss, measured at 6-month and 12-month intervals, was found to have halted and hair growth to have improved in the twins who'd used dutasteride. Meanwhile, the twins on placebo continued to lose hair.

In this article on the American Hair Loss Association site, dutasteride is described as being a "promising" treatment manufactured by GlaxoSmithKline, sold under the brand name Avodart. The article's author also states the opinion that dutasteride will provide better results for women's hair loss than "any other medication currently available."


Most Recent Posts


Previous Posts